Helga Zharov
Conseiller Juridique Général chez ALVOTECH
Fortune : - $ au 30/04/2024
Profil
Helga Tatjana Zharov is currently the Deputy Chief Executive Officer at Alvotech hf, the Director at Reykjavik University, the Director at Skólavegur ehf, the Director at Talna ehf, and the Secretary & General Counsel at Alvotech.
Previously, she held positions such as Deputy Chief Executive Officer at deCODE Genetics ehf, Director at ORF Genetics, Independent Director at Sýn hf, Director at CRI hf., Director at Íslandsbanki hf, Secretary & Vice President-Administration at deCODE genetics, Inc., Partner & Tax Attorney at PricewaterhouseCoopers hf, MD-Legal, General Counsel & Compliance Officer at Virding hf, General Counsel at Auður Capital hf, and Secretary & Vice President-Corporate Governance at deCODE Genetics ehf.
She obtained a graduate degree from the University of Iceland.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALVOTECH
-.--% | 15/02/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Helga Zharov
| Sociétés | Poste | Début |
|---|---|---|
| ALVOTECH | Conseiller Juridique Général | 01/01/2023 |
| Talna ehf | Directeur/Membre du Conseil | - |
| Skólavegur ehf | Directeur/Membre du Conseil | - |
Alvotech hf
 Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Corporate Officer/Principal | 01/05/2020 |
| Reykjavik University | Directeur/Membre du Conseil | - |
Anciens postes connus de Helga Zharov
| Sociétés | Poste | Fin |
|---|---|---|
deCODE Genetics ehf
 deCODE Genetics ehf Miscellaneous Commercial ServicesCommercial Services deCODE genetics engages in a biopharmaceuticals company. It provides research services with focus on human genes. The company was founded by K?ri Stef?nsson in August 1996 and is headquartered in Reykjavik, Iceland. | Corporate Officer/Principal | 01/01/2020 |
Virding hf
 Virding hf Investment ManagersFinance Virding hf provides financial services. It operates through four segments: Asset Management, Capital Markets, Corporate Finance and Private Equity Funds. The Asset Management segment offers asset management services that are tailored to the needs of high net worth individuals, pension funds, NGOs and institutional investors. The segment also offers independent advice and personal assistance. The Capital Markets segment works as intermediaries for investments in a wide variety of asset classes for Iceland´s largest investors and international clients such as corporate, institutional investors, UCITS, pension funds, public entities and other professional investors. The Corporate Finance segment offers its clients a wide range of advisory services including fund raising, corporate and financial restructuring, M&A and company divestitures. The Private Equity Funds segment invests in small to medium-size Icelandic companies with a strong market position and attractive growth potential. The company was founded in 1999 and is headquartered in Reykjavík, Iceland. | Compliance Officer | 01/01/2015 |
deCODE Genetics ehf
deCODE Genetics ehf Miscellaneous Commercial ServicesCommercial Services deCODE genetics engages in a biopharmaceuticals company. It provides research services with focus on human genes. The company was founded by K?ri Stef?nsson in August 1996 and is headquartered in Reykjavik, Iceland. | Directeur Administratif | 01/12/2007 |
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Directeur Administratif | - |
| ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Helga Zharov
| University of Iceland | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SÝN HF. | Communications |
| ALVOTECH | Health Technology |
| ÍSLANDSBANKI HF. | Finance |
| Entreprise privées | 10 |
|---|---|
CRI hf.
 CRI hf. Chemicals: SpecialtyProcess Industries CRI hf. captures carbon dioxide from industrial emissions and converts carbon dioxide into renewable methanol. It produces renewable methanol from carbon dioxide, hydrogen and electricity for energy storage, fuel applications and enhancement. The firm serves the following industries: bio diesel production, chemicals, gasoline blending, and wastewater treatment industries. Its services include project partnership, feasibility to investment, project execution, and lifetime operation services. The company was founded by Oddur Ingólfsson, Arthur Shulenberger, Fridrik Jonsson, and K-C Tran in 2006 and is headquartered in Kopavogur, Iceland. | Process Industries |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Health Technology |
ORF Genetics
 ORF Genetics BiotechnologyHealth Technology ORF Genetics is a plant biotechnology company that specializes in developing and manufacturing high-quality recombinant proteins derived from barley plants. The private company is based in Kópavogur, Iceland. The Icelander company's products include Isokine, which are highly purified, easily scalable, endotoxin-free growth factors produced in their barley plants. The company also offers Mesokine, animal-like growth factors produced in barley plants for the development of cell cultured meat and related industries. Liv Bergþórsdóttir has been the CEO of the company since 2020. | Health Technology |
PricewaterhouseCoopers hf
 PricewaterhouseCoopers hf Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers hf is a company based in Iceland, Iceland. | Commercial Services |
Virding hf
Virding hf Investment ManagersFinance Virding hf provides financial services. It operates through four segments: Asset Management, Capital Markets, Corporate Finance and Private Equity Funds. The Asset Management segment offers asset management services that are tailored to the needs of high net worth individuals, pension funds, NGOs and institutional investors. The segment also offers independent advice and personal assistance. The Capital Markets segment works as intermediaries for investments in a wide variety of asset classes for Iceland´s largest investors and international clients such as corporate, institutional investors, UCITS, pension funds, public entities and other professional investors. The Corporate Finance segment offers its clients a wide range of advisory services including fund raising, corporate and financial restructuring, M&A and company divestitures. The Private Equity Funds segment invests in small to medium-size Icelandic companies with a strong market position and attractive growth potential. The company was founded in 1999 and is headquartered in Reykjavík, Iceland. | Finance |
Auður Capital hf
 Auður Capital hf Investment ManagersFinance Audur Capital hf (Audur Capital) is an Alternative Investment management firm, specializing in wealth management, private equity advice and corporate advice. The firm was established in 2007 by Halla Tomasdottic and Kristin Petursdottir and is located in Iceland. | Finance |
| Talna ehf | |
| Skólavegur ehf | |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Health Technology |
deCODE Genetics ehf
deCODE Genetics ehf Miscellaneous Commercial ServicesCommercial Services deCODE genetics engages in a biopharmaceuticals company. It provides research services with focus on human genes. The company was founded by K?ri Stef?nsson in August 1996 and is headquartered in Reykjavik, Iceland. | Commercial Services |
